Regulation of PI 3-K, PTEN, p53, and mTOR in Malignant and Benign Tumors Deficient in Tuberin

Genes and Cancer

Volumn 2, Issue 11, 2011, Pages 1051-1060

  Habib, Samy L ^a,b   Yadav, Anamika ^a   Mahimainathan, Lenin ^c   Valente, Anthony J ^d  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^c TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^d Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

angiomyolipoma; p53; PTEN; RCC; tuberin

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53; TUBERIN;

ANGIOMYOLIPOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BENIGN TUMOR; CANCER GROWTH; CARCINOGENESIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

RATTUS;

EID: 84868653929     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: 10.1177/1947601912445376     Document Type: Article

References (35)

1. Carsillo T,Astrinidis A,Henske EP.Mutations in the tuberous sclerosis complex gene TSC-2 are a cause of sporadic pulmonary lymphangioleiomyomatosis.Proc Natl Acad Sci U S A. 2000;97:6085-90.
2. Stillwell TJ,Gomez MR,Kelalis PP.Renal lesions in tuberous sclerosis.J Urol. 1987;138:477-81.
3. Al-Saleem T,Wessner LL,Scheithauer BW, et al.Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex.Cancer. 1998;83:2208-16.
4. Bissler JJ,Kingswood JC.Renal angiomyolipomata.Kidney Int. 2004;66:924-34.
5. Shapiro RA,Skinner DG,Stamley P, et al.Renal tumors associated with tuberous sclerosis: the case for aggressive surgical management.J Urol. 1984;132:1170-4.
6. Habib SL.Insight into mechanism of oxidative DNA damage in angiomyolipoma from TSC patients.Mol Cancer. 2009;8:8-13.
7. McDorman KS,Wolf DC.Use of the spontaneous TSC-2 knockout (Eker) rat model of hereditary renal cell carcinoma for the study of renal carcinogens.Toxicol Pathol. 2002;30:675-80.
8. Eker R,Mossige J.A dominant gene for renal adenomas in the rat.Nature. 1961;189:858-9.
9. Habib SL,Simone S,Barnes JJ, et al.Tuberin haploinsufficiency is associated with the loss of OGG1 in rat kidney tumors.Mol Cancer. 2008;7:10-4.
10. Habib SL,Phan MN,Patel SK, et al.Reduced constitutive 8-oxoguanine-DNA glycosylase expression and impaired induction following oxidative DNA damage in the tuberin deficient Eker rat.Carcinogenesis. 2003;24:573-82.
11. Vivanco I,Sawyers CL.The phosphatidylinositol 3-kinase AKT pathway in human cancer.Nat Rev Cancer. 2002;2:489-501.
12. Blume-Jensen P,Hunter T.Oncogenic kinase signaling.Nature. 2001;411:355-65.
13. Wang H,Karikomi M,Naidu S, et al.Allele-specific tumor spectrum in PTEN knockin mice.Proc Natl Acad Sci U S A. 2010;107:5142-7.
14. Stambolic V,Suzuki A,de la Pompa JL, et al.Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.Cell. 1998;95:29-39.
15. Manning BD,Tee AR,Logsdon MN, et al.Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/Akt pathway.Mol Cell. 2002;10:151-62.
16. Sun H,Lesche R,Li DM, et al.PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway.Proc Natl Acad Sci U S A. 1999;96:6199-204.
17. Mehta MS,Vazquez A,Kulkarni DA, et al.Polymorphic variants in TSC1 and TSC-2 and their association with breast cancer phenotypes.Breast Cancer Res Treat. 2011;125:861-8.
18. Chakraborty S,Mohiyuddin SM,Gopinath KS, et al.Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma.BMC Cancer. 2008;8:163-6.
19. Cantley LC,Neel BG.New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway.Proc Natl Acad Sci U S A. 1999;96:4240-5.
20. Cully M,You H,Levine AJ, et al.Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis.Nat Rev Cancer. 2006;6:184-92.
21. Li J,Yen C,Liaw D, et al.PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.Science. 1997;275:1943-7.
22. Lee CH,Inoki K,Karbowniczek M, et al.Constitutive mTOR activation in TSC mutants sensitizes cells to energy starvation and genomic damage via p53.EMBO J. 2007;26:4812-23.
23. Stambolic V,MacPherson D,Sas D, et al.Regulation of PTEN transcription by p53.Cancer Cell. 2001;8:317-25.
24. Horesovsky G,Recio L,Everitt J, et al.p53 status in spontaneous and dimethylnitrosamine-induced renal cell tumors from rats.Mol Carcinog. 1995;12:236-40.
25. Feng Z,Zhang H,Levine AJ,Jin S.The coordinate regulation of the p53 and mTOR pathways in cells.Proc Natl Acad Sci U S A. 2005;102:8204-9.
26. Mahimainathan L,Ghosh-Choudhury N,Venkatesan B, et al.TSC-2 deficiency increases PTEN via HIF1alpha.J Biol Chem. 2009;284:27790-8.
27. Henske EP,Scheithauer BW,Short MP, et al.Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions.Genes Chromosomes Cancer. 1995;13:295-8.
28. Crino PB,Nathanson KL,Henske EP.The tuberous sclerosis complex.N Engl J Med. 2006;355:1345-56.
29. Martignoni G,Pea M,Bonetti F, et al.Carcinomalike monotypic epithelioid angiomyolipoma in patients without evidence of tuberous sclerosis: a clinicopathologic and genetic study.Am J Surg Pathol. 1998;22:663-72.
30. Cheadle JP,Reeve MP,Sampson JR, et al.Molecular genetic advances in tuberous sclerosis.Hum Genet. 2000;107:97-114.
31. Kenerson HL,Aicher LD,True LD, et al.Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors.Cancer Res. 2002;62:5645-50.
32. Phillips WA,St Clair F,Munday AD, et al.Increased levels of phosphatidylinositol 3-kinase activity in colorectal tumors.Cancer. 1998;83:41-7.
33. Habib SL,Bhandari BK,Sadek N, et al.Novel mechanism of regulation of the DNA repair enzyme OGG1 in tuberin-deficient cells.Carcinogenesis. 2010;31:2022-30.
34. Bradford MM.A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.Anal Biochem. 1976;72:248-54.
35. Habib SL,Kasinath BS,Arya RR, et al.Novel mechanism of reducing tumourigenesis: upregulation of the DNA repair enzyme OGG1 by rapamycin-mediated AMPK activation and mTOR inhibition.Eur J Cancer. 2010;46:2806-20.